Establishing an AI Centre of Excellence to Revolutionize Drug Discovery, Clinical Trials, and Supply Chain Optimization
— Service Area
Digital and AI Transformation
— Focus Area
AI Centre of Excellence Development
AI-Driven Drug Discovery & Clinical Trials Optimization
AI in Pharmaceutical Manufacturing & Supply Chain
Standardized Digital Innovation Frameworks
AI Governance & Compliance Strategy
— CLIENT
- A Global Biopharmaceutical Company
Interested in learning more?
Explore our Services and Case Studies.
— Challange
A leading pharmaceutical company sought to accelerate digital innovation by establishing an AI Centre of Excellence (CoE) to enhance drug discovery, optimize clinical trials, and modernize supply chain operations. The primary challenge was to build a centralized hub that could drive cross-functional collaboration, standardize AI initiatives, and align digital transformation with broader corporate objectives.
Key challenges included:
- Lack of AI standardization across R&D, clinical, and manufacturing functions.
- Siloed digital innovation efforts leading to inefficiencies and slow adoption.
- Regulatory and compliance complexities around AI-driven decision-making in pharma.
- Operational inefficiencies in supply chain and manufacturing due to outdated digital capabilities.
— Approach
Peyman spearheaded the creation of a global AI Centre of Excellence, ensuring a structured and scalable approach to AI adoption. Key initiatives included:
- AI Centre of Excellence Development
- Designed a centralized AI innovation framework for company-wide implementation.
- Established AI governance models ensuring compliance and risk management.
- Created a strategic AI roadmap prioritizing high-impact use cases.
- AI-Driven Drug Discovery & Clinical Trials Optimization
- Implemented AI-powered predictive analytics to enhance early-stage drug discovery.
- Designed a framework for AI models to accelerate clinical trial recruitment and patient stratification.
- Integrated digital biomarkers and remote monitoring solutions into clinical trial workflows.
- AI in Pharmaceutical Manufacturing & Supply Chain
- Developed an AI-powered supply chain optimization framework to improve forecasting and reduce waste.
- Implemented predictive maintenance in manufacturing facilities to reduce downtime and costs.
- Enhanced automation and real-time analytics in pharmaceutical production.
- Standardized Digital Innovation Frameworks
- Established best practices for AI adoption across R&D, clinical, and commercial functions.
- Facilitated cross-functional collaboration between data scientists, regulatory teams, and business units.
- Developed AI training programs to upskill teams and foster innovation culture.
- AI Governance & Compliance Strategy
- Ensured alignment with global regulatory frameworks on AI applications in pharma.
- Created transparent AI validation protocols to build trust in AI-driven decisions.
- Implemented data privacy and security measures to safeguard sensitive information.
— Expected Results
- Accelerated drug discovery processes through AI-driven predictive modeling.
- Optimized clinical trial efficiency, reducing time-to-market for new therapies.
- Cost reductions in supply chain and manufacturing through AI-based automation and predictive maintenance.
- Improved regulatory compliance via structured AI governance models.
- Enhanced AI-driven decision-making, enabling better resource allocation and business outcomes.
Ready to Build Your Digital Innovation Hub & AI Centre of Excellence?
Accelerate your AI-driven pharmaceutical transformation with Peyman Advisory. Whether you need to establish a Digital Innovation Hub, optimize clinical trials, or modernize supply chain operations, we offer strategic advisory, AI innovation workshops, and end-to-end project execution.
Contact us today to start your AI transformation journey.